Greenlight Capital Re (NASDAQ:GLRE – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “strong-buy” rating in a research report issued on Saturday. Separately, Weiss Ratings restated a “hold (c-)” rating on shares of Greenlight Capital Re in a research report on Monday, December 29th. One […]

Orchestra BioMed (NASDAQ:OBIO – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “strong sell” rating to a “hold” rating in a report issued on Saturday. A number of other equities research analysts also recently weighed in on the company. Barclays boosted their price target on Orchestra BioMed from […]

TuHURA Biosciences (NASDAQ:HURA – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday. A number of other equities analysts also recently issued reports on the stock. HC Wainwright reissued a “buy” rating and issued a $10.00 price […]

ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) was upgraded by Wall Street Zen from a “strong sell” rating to a “hold” rating in a note issued to investors on Saturday. Several other equities research analysts also recently weighed in on PRQR. Citigroup reissued a “market outperform” rating on shares of ProQR Therapeutics in a report […]

Viant Technology (NASDAQ:DSP – Get Free Report) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday. A number of other analysts also recently weighed in on DSP. B. Riley Financial reiterated a “buy” rating and set a $17.00 target […]

Virtuix (NASDAQ:VTIX – Get Free Report) was upgraded by equities research analysts at Wall Street Zen to a “hold” rating in a note issued to investors on Saturday. Virtuix Stock Performance NASDAQ VTIX opened at $6.77 on Friday. Virtuix has a 1-year low of $4.39 and a 1-year high of $92.74. Virtuix (NASDAQ:VTIX – Get […]

Evolus (NASDAQ:EOLS – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. Several other research analysts have also commented on EOLS. Needham & Company LLC reaffirmed a “hold” rating on shares of Evolus in a research report on […]

PepsiCo (NASDAQ:PEP – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. Several other equities analysts have also weighed in on PEP. Evercore increased their price objective on shares of PepsiCo from $152.00 to $165.00 in a […]

ADMA Biologics (NASDAQ:ADMA – Get Free Report) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday. Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of ADMA Biologics in a research report on Tuesday, December 23rd. […]